Bronchodilators Market Research Report Information By Drug Type (Adrenergic drugs, Anticholinergics, Phosphodiesterase Inhibitor, Combination Drugs), By Disease (Asthma, COPD, Others), By Mode of Action (Short-Acting Bronchodilators, Long-Acting Bronchodilators) and By Route of Administration (Oral, Parenteral) – Forecast to 2032

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Bronchodilators Market, by Drug Type

1.1.2. Global Bronchodilators Market, by Disease

1.1.3. Global Bronchodilators Market, by Mode of Action

1.1.4. Global Bronchodilators Market, by Route of Administration

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.5. Breakdown of Primary Respondents

3.6. Forecasting Techniques

3.7. Research Methodology for Market Size Estimation

3.8. Bottom-Up Approach

3.9. Top-Down Approach

3.10. Data Triangulation

3.11. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

6. GLOBAL BRONCHODILATORS MARKET, BY DRUG TYPE

6.1. Overview

6.2. Adrenergic drugs

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.3. Anticholinergics

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.4. Phosphodiesterase Inhibitor

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

6.5. Combination Drugs

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7. GLOBAL BRONCHODILATORS MARKET, BY DISEASE

7.1. Overview

7.2. Asthma

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.3. COPD

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

7.4. Others

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8. GLOBAL BRONCHODILATORS MARKET, BY MODE OF ACTION

8.1. Overview

8.2. Long-Acting Bronchodilators

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

8.3. Short-Acting Bronchodilators

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

9. GLOBAL BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION

9.1. Overview

9.2. Oral

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

9.3. Parenteral

Market Estimates & Forecast, by Region, 2022-2030

Market Estimates & Forecast, by Country, 2022-2030

10. GLOBAL BRONCHODILATORS MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitor Dashboard

11.3. Major Growth Strategy in the Global Bronchodilators Market

11.4. Competitive Benchmarking

11.5. The Leading Player in terms of Number of Developments in the Global Bronchodilators Market

11.6. Key Developments & Growth Strategies

11.7. Major Players Financial Matrix & Market Ratio

12. COMPANY PROFILES

12.1. GlaxoSmithKline

12.1.1. Company Overview

12.1.2. Drugs/Services Offered

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Novartis AG

12.3. Merck & Co., Inc.

12.4. Abbott Laboratories

12.5. Boehringer Ingelheim GmbH

12.6. AstraZeneca plc

12.7. F. Hoffmann LA-Roche AG

12.8. Teva Pharmaceutical

12.9. Pfizer Inc.

12.10. Others

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL BRONCHODILATORS MARKET SYNOPSIS, 2022-2030

TABLE 2 GLOBAL BRONCHODILATORS MARKET ESTIMATES & FORECAST, 2022-2030 (USD Billion)

TABLE 3 GLOBAL BRONCHODILATORS MARKET, BY DRUG TYPE, 2022-2030 (USD Billion)

TABLE 4 GLOBAL BRONCHODILATORS MARKET, BY DISEASE, 2022-2030 (USD Billion)

TABLE 5 GLOBAL BRONCHODILATORS MARKET, BY MODE OF ACTION, 2022-2030 (USD Billion)

TABLE 6 GLOBAL BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD Billion)

TABLE 7 GLOBAL BRONCHODILATORS MARKET, BY REGION, 2022-2030 (USD Billion)

TABLE 8 NORTH AMERICA: BRONCHODILATORS MARKET, BY DRUG TYPE, 2022-2030 (USD Billion)

TABLE 9 NORTH AMERICA: BRONCHODILATORS MARKET, BY DISEASE, 2022-2030 (USD Billion)

TABLE 10 NORTH AMERICA: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2022-2030 (USD Billion)

TABLE 11 NORTH AMERICA BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD Billion)

TABLE 12 US: BRONCHODILATORS MARKET, BY DRUG TYPE, 2022-2030 (USD Billion)

TABLE 13 US: BRONCHODILATORS MARKET, BY DISEASE, 2022-2030 (USD Billion)

TABLE 14 US: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2022-2030 (USD Billion)

TABLE 15 US: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD Billion)

TABLE 16 CANADA: BRONCHODILATORS MARKET, BY DRUG TYPE, 2022-2030 (USD Billion)

TABLE 17 CANADA: BRONCHODILATORS MARKET, BY DISEASE, 2022-2030 (USD Billion)

TABLE 18 CANADA: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2022-2030 (USD Billion)

TABLE 19 CANADA: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD Billion)

TABLE 20 LATIN AMERICA: BRONCHODILATORS MARKET, BY DRUG TYPE, 2022-2030 (USD Billion)

TABLE 21 LATIN AMERICA: BRONCHODILATORS MARKET, BY DISEASE, 2022-2030 (USD Billion)

TABLE 22 LATIN AMERICA: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2022-2030 (USD Billion)

TABLE 23 LATIN AMERICA: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD Billion)

TABLE 24 EUROPE: BRONCHODILATORS MARKET, BY DRUG TYPE, 2022-2030 (USD Billion)

TABLE 25 EUROPE: BRONCHODILATORS MARKET, BY DISEASE, 2022-2030 (USD Billion)

TABLE 26 EUROPE: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2022-2030 (USD Billion)

TABLE 27 EUROPE: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD Billion)

TABLE 28 WESTERN EUROPE: BRONCHODILATORS MARKET, BY DRUG TYPE, 2022-2030 (USD Billion)

TABLE 29 WESTERN EUROPE: BRONCHODILATORS MARKET, BY DISEASE, 2022-2030 (USD Billion)

TABLE 30 WESTERN EUROPE: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2022-2030 (USD Billion)

TABLE 31 WESTERN EUROPE: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD Billion)

TABLE 32 EASTERN EUROPE: BRONCHODILATORS MARKET, BY DRUG TYPE, 2022-2030 (USD Billion)

TABLE 33 EASTERN EUROPE: BRONCHODILATORS MARKET, BY DISEASE, 2022-2030 (USD Billion)

TABLE 34 EASTERN EUROPE: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2022-2030 (USD Billion)

TABLE 35 EASTERN EUROPE: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD Billion)

TABLE 36 ASIA-PACIFIC: BRONCHODILATORS MARKET, BY DRUG TYPE, 2022-2030 (USD Billion)

TABLE 37 ASIA-PACIFIC: BRONCHODILATORS MARKET, BY DISEASE, 2022-2030 (USD Billion)

TABLE 38 ASIA-PACIFIC: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2022-2030 (USD Billion)

TABLE 39 ASIA-PACIFIC: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD Billion)

TABLE 40

TABLE 41 MIDDLE EAST & AFRICA: BRONCHODILATORS MARKET, BY DRUG TYPE, 2022-2030 (USD Billion)

TABLE 42 MIDDLE EAST & AFRICA: BRONCHODILATORS MARKET, BY DISEASE, 2022-2030 (USD Billion)

TABLE 43 MIDDLE EAST & AFRICA: BRONCHODILATORS MARKET, BY MODE OF ACTION, 2022-2030 (USD Billion)

TABLE 44 MIDDLE EAST & AFRICA: BRONCHODILATORS MARKET, BY ROUTE OF ADMINISTRATION, 2022-2030 (USD Billion)  

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BRONCHODILATORS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BRONCHODILATORS MARKET

FIGURE 4 GLOBAL BRONCHODILATORS MARKET SHARE, BY DRUG TYPE, 2022 (%)

FIGURE 5 GLOBAL BRONCHODILATORS MARKET SHARE, BY DISEASE, 2022 (%)

FIGURE 6 GLOBAL BRONCHODILATORS MARKET SHARE, BY MODE OF ACTION, 2022 (%)

FIGURE 7 GLOBAL BRONCHODILATORS MARKET SHARE, BY ROUTE OF ADMINISTRATION, 2022 (%)

FIGURE 8 GLOBAL BRONCHODILATORS MARKET SHARE, BY REGION, 2022 (%)

FIGURE 9 AMERICAS: BRONCHODILATORS MARKET SHARE BY REGION, 2022 (%)

FIGURE 10 NORTH AMERICA: BRONCHODILATORS MARKET SHARE, BY COUNTRY, 2022 (%)

FIGURE 11 EUROPE: BRONCHODILATORS MARKET SHARE, BY REGION, 2022 (%)

FIGURE 12 WESTERN EUROPE: BRONCHODILATORS MARKET SHARE, BY COUNTRY, 2022 (%)

FIGURE 13 ASIA-PACIFIC: BRONCHODILATORS MARKET SHARE, BY COUNTRY, 2022 (%)

FIGURE 14 MIDDLE EAST & AFRICA: BRONCHODILATORS MARKET SHARE, BY COUNTRY, 2022 (%)

FIGURE 15 GLOBAL BRONCHODILATORS MARKET: COMPANY SHARE ANALYSIS, 2022 (%)

FIGURE 16 GLAXOSMITHKLINE PLC: KEY FINANCIALS

FIGURE 17 GLAXOSMITHKLINE PLC: SEGMENTAL REVENUE

FIGURE 18 GLAXOSMITHKLINE PLC: REGIONAL REVENUE

FIGURE 19 NOVARTIS AG: KEY FINANCIALS

FIGURE 20 NOVARTIS AG: SEGMENTAL REVENUE

FIGURE 21 NOVARTIS AG: REGIONAL REVENUE

FIGURE 22 MERCK: KEY FINANCIALS

FIGURE 23 MERCK: SEGMENTAL REVENUE

FIGURE 24 MERCK: REGIONAL REVENUE

FIGURE 25 ABBOTT: KEY FINANCIALS

FIGURE 26 ABBOTT: SEGMENTAL REVENUE

FIGURE 27 ABBOTT.: REGIONAL REVENUE

FIGURE 28 BOEHRINGER INGELHEIM GMBH: KEY FINANCIALS

FIGURE 29 BOEHRINGER INGELHEIM GMBH: SEGMENTAL REVENUE

FIGURE 30 BOEHRINGER INGELHEIM GMBH: REGIONAL REVENUE

FIGURE 31 ASTRAZENECA: KEY FINANCIALS

FIGURE 32 ASTRAZENECA: SEGMENTAL REVENUE

FIGURE 33 ASTRAZENECA: REGIONAL REVENUE

FIGURE 34 F. HOFFMANN-LA ROCHE AG: KEY FINANCIALS

FIGURE 35 F. HOFFMANN-LA ROCHE AG: SEGMENTAL REVENUE

FIGURE 36 F. HOFFMANN-LA ROCHE AG: REGIONAL REVENUE

FIGURE 37 TEVA PHARMACEUTICAL: KEY FINANCIALS

FIGURE 38 TEVA PHARMACEUTICAL: SEGMENTAL REVENUE

FIGURE 39 TEVA PHARMACEUTICAL: REGIONAL REVENUE

FIGURE 40 PFIZER.: KEY FINANCIALS

FIGURE 41 PFIZER.: SEGMENTAL REVENUE

FIGURE 42 PFIZER.: REGIONAL REVENUE